Unicycive Therapeutics (UNCY) Institutional Ownership $0.65 0.00 (-0.25%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$0.65 0.00 (-0.15%) As of 05/1/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Unicycive Therapeutics (NASDAQ:UNCY)CurrentInstitutional OwnershipPercentage40.42%Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$20.51MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$2.01M Get UNCY Insider Trade Alerts Want to know when executives and insiders are buying or selling Unicycive Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data UNCY Institutional Buying and Selling by Quarter Unicycive Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Octagon Capital Advisors LP10,000,000$7.94M1.3%+16.8%9.634% 2/17/2025Alyeska Investment Group L.P.1,750,000$1.39M0.0%-22.2%1.686% 2/17/2025Acuta Capital Partners LLC2,303,000$1.83M1.8%+16.4%2.219% 2/14/2025Nantahala Capital Management LLC10,391,994$8.25M0.4%+268.5%10.012% 2/14/2025Northern Trust Corp58,181$46K0.0%+142.4%0.056% 2/14/2025Silverarc Capital Management LLC2,486,709$1.98M0.4%-37.8%2.396% 2/14/2025Vivo Capital LLC9,970,152$7.92M0.9%+123.0%9.605% 2/13/2025XTX Topco Ltd171,463$136K0.0%+142.2%0.165% 2/12/2025Geode Capital Management LLC524,487$417K0.0%+30.3%0.505% 11/20/2024Virtu Financial LLC73,975$30K0.0%+566.8%0.071% Get the Latest News and Ratings for UNCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Unicycive Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024XTX Topco Ltd70,784$29K0.0%N/A0.075% 11/14/2024Walleye Capital LLC5,000,000$2.04M0.0%N/A5.299% 11/14/2024Acuta Capital Partners LLC1,979,199$807K0.7%N/A2.097% 11/13/2024Great Point Partners LLC8,559,000$3.49M1.0%N/A9.071% 10/16/2024Bleakley Financial Group LLC80,000$33K0.0%N/A0.085% 8/20/2024Nantahala Capital Management LLC2,820,358$1.41M0.1%-15.4%7.499% 7/12/2024Rosalind Advisors Inc.1,571,200$787K0.6%-16.4%4.178% 5/20/2024Virtu Financial LLC26,082$36K0.0%N/A0.069% 5/16/2024BVF Inc. IL3,611,601$4.98M0.1%+70.5%9.603% 4/25/2024Rosalind Advisors Inc.1,879,646$2.59M2.4%N/A5.407% 2/15/2024BVF Inc. IL2,118,139$1.84M0.0%-37.9%6.095% 11/15/2023RA Capital Management L.P.3,470,688$2.99M0.1%N/A9.987% 11/8/2023Vivo Capital LLC3,470,152$2.98M0.4%N/A9.986% 8/10/2023Ground Swell Capital LLC20,001$26K0.1%N/A0.131% 4/26/2023Oxbow Advisors LLC11,861$25K0.0%N/A0.078% 2/15/2023Nantahala Capital Management LLC647,416$350K0.0%-8.9%4.302% 11/15/2022Board of Trustees of The Leland Stanford Junior University63,019$37K0.0%-74.5%0.419% 11/10/2022Nantahala Capital Management LLC710,542$419K0.0%-2.6%4.721% 8/15/2022Nantahala Capital Management LLC729,680$606K0.0%+13.9%4.855% 4/22/2022 Truist Financial Corp37,462$48K0.0%N/A0.250% 11/12/2021Board of Trustees of The Leland Stanford Junior University247,583$700K0.1%N/A1.707% 11/9/2021BlackRock Inc.11,443$33K0.0%N/A0.079% 10/28/2021 Tandem Capital Management Corp ADV15,500$44K0.0%N/A0.107% (Data available from 1/1/2016 forward) UNCY Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of UNCY shares? During the previous two years, 17 institutional investors and hedge funds held shares of Unicycive Therapeutics. The most heavily invested institutionals were Nantahala Capital Management LLC ($8.25M), Octagon Capital Advisors LP ($7.94M), Vivo Capital LLC ($7.92M), BVF Inc. IL ($4.98M), Great Point Partners LLC ($3.49M), RA Capital Management L.P. ($2.99M), and Walleye Capital LLC ($2.04M).Learn more on UNCY's institutional investors. What percentage of Unicycive Therapeutics stock is owned by institutional investors? 40.42% of Unicycive Therapeutics stock is owned by institutional investors. Learn more on UNCY's institutional investor holdings. Which institutional investors have been buying Unicycive Therapeutics stock? Of the 15 institutional investors that purchased Unicycive Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vivo Capital LLC ($8.97M), Great Point Partners LLC ($8.56M), Nantahala Capital Management LLC ($7.57M), Walleye Capital LLC ($5M), RA Capital Management L.P. ($3.47M), Acuta Capital Partners LLC ($2.30M), and Rosalind Advisors Inc. ($1.88M). How much institutional buying is happening at Unicycive Therapeutics? Institutional investors have bought a total of 41,205,283 shares in the last 24 months. This purchase volume represents approximately $29.10M in transactions. Which Unicycive Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Unicycive Therapeutics stock in the last 24 months: Silverarc Capital Management LLC ($1.51M), BVF Inc. IL ($1.30M), Nantahala Capital Management LLC ($515.23K), Alyeska Investment Group L.P. ($500K), and Rosalind Advisors Inc. ($308.45K). How much institutional selling is happening at Unicycive Therapeutics? Institutional investors have sold a total of 4,132,389 shares in the last 24 months. This volume of shares sold represents approximately $3.14M in transactions. Related Companies Atyr PHARMA Major Shareholders Atai Life Sciences Major Shareholders Palvella Therapeutics Major Shareholders Aura Biosciences Major Shareholders Cryoport Major Shareholders Monte Rosa Therapeutics Major Shareholders Phathom Pharmaceuticals Major Shareholders Cartesian Therapeutics Major Shareholders 2seventy bio Major Shareholders Monopar Therapeutics Major Shareholders This page (NASDAQ:UNCY) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unicycive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Unicycive Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UNCY Stock Free UNCY Stock Alerts